Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel

Affiliations

• ¹ Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada. Electronic address: todd.anderson@albertahealthservices.ca.
• ² Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada.
• ³ Robarts Research Institute, London, Ontario, Canada.
• ⁴ Centre hospitalier universitaire de Québec, Québec City, Québec, Canada.
• ⁵ Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁶ University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
• ⁷ St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁸ Institut universitaire de cardiologie et de pneumologie de Québec, Faculté de pharmacie, Université Laval, Quebec City, Québec, Canada.
• ⁹ Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
• ¹⁰ McGill University Health Center, Montreal, Québec, Canada.
• ¹¹ Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
• ¹² Institut de recherches cliniques de Montréal, Montréal, Québec, Canada.
• ¹³ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
• ¹⁴ Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada.
• ¹⁵ Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
• ¹⁶ Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
• ¹⁷ Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Ontario.
• ¹⁸ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
• ¹⁹ QE II Health Sciences Centre, Halifax, Nova Scotia, Canada.